James T. Parsons, a director at Oncolytics Biotech Inc. ($ONCY), made one open market purchase of common shares in the last 365 days, totaling $10,300. His most recent buy occurred on March 11, 2026. This ranks him 4,249th among 4,983 individual insiders by purchase amount, compared to an average of $1.46 million per insider and 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | ONCOLYTICS BIOTECH INC | $ONCY | Parsons James T. | Director | P | Common Shares | 10000 | $1.03 | 41,849.0000 | 80,020,131 | 31.40% | 0.01% |
| Jan. 2, 2026 | DiaMedica Therapeutics Inc. | $DMAC | Parsons James T. | Not found | A | Common Stock | 10095 | $8.42 | 97,949.0000 | 52,077,439 | 11.49% | 0.02% |
| Nov. 21, 2025 | DiaMedica Therapeutics Inc. | $DMAC | Parsons James T. | Not found | M | Common Stock | 12000 | $2.20 | 87,854.0000 | 52,077,439 | 15.82% | 0.02% |
| Nov. 21, 2025 | DiaMedica Therapeutics Inc. | $DMAC | Parsons James T. | Not found | M | Stock Option (right to buy) | 12000 | $0.00 | 0.0000 | 52,077,439 | 100.00% | 0.02% |
| June 1, 2025 | DiaMedica Therapeutics Inc. | $DMAC | Parsons James T. | Director | A | Stock Option (right to buy) | 40739 | $0.00 | 40,739.0000 | 42,855,660 | 9999.99% | 0.10% |
| Jan. 2, 2025 | DiaMedica Therapeutics Inc. | $DMAC | Parsons James T. | Director | A | Voting Common Shares, no par value per share | 15917 | $5.34 | 75,854.0000 | 0 | 26.56% | 0.00% |
| Jan. 2, 2025 | DiaMedica Therapeutics Inc. | $DMAC | Parsons James T. | Director | A | Stock Option (right to buy) | 4287 | $0.00 | 4,287.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2024 | DiaMedica Therapeutics Inc. | $DMAC | Parsons James T. | Director | A | Stock Option (right to buy) | 28472 | $0.00 | 28,472.0000 | 0 | 9999.99% | 0.00% |
| Jan. 2, 2024 | DiaMedica Therapeutics Inc. | $DMAC | Parsons James T. | Director | A | Voting Common Shares, no par value per share | 21428 | $2.80 | 59,937.0000 | 0 | 55.64% | 0.00% |
| June 1, 2023 | DiaMedica Therapeutics Inc. | $DMAC | Parsons James T. | Director | A | Stock Option (right to buy) | 16968 | $0.00 | 16,968.0000 | 0 | 9999.99% | 0.00% |